Article citationsMore>>

Bertolami, C., Gay, T., Clark, G., Rendell, J., Shetty, V., Liu, C., et al. (1993) Use of Sodium Hyaluronate in Treating Temporomandibular Joint Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Journal of Oral and Maxillofacial Surgery, 51, 232-242.
https://doi.org/10.1016/S0278-2391(10)80163-6

has been cited by the following article:

• TITLE: Clinical Evaluation of Platelet Rich Growth Factors (PRGFS) in Treatment of Temporomandibular Joint Disc Displacement—Study Report

  AUTHORS: Lahaou Baladji Touré, Oumar Ongoïba, Djibril Kassogué, Wael Ahmed Elmohandes, Elsaeed Mohamed Abdellatif

  KEYWORDS: Platelet Rich Growth Factors, Platelet Rich Plasma, Temporomandibular Joint

  JOURNAL NAME: Open Journal of Stomatology, Vol.13 No.5, May 24, 2023

  ABSTRACT: Objective: The aim of the study was to evaluate the effect of platelet rich growth factors (PRGFs) in treatment of temporomandibular joint disc displacement. Materials and Methods: The study subjects included 8 females having bilateral anterior disc displacement with reduction and 1 female having bilateral anterior disc displacement without reduction with the age range between 20 - 35 years. The process of obtaining PRGFs was carried out following the Anitua Technique. Results: Clinical parameters of Interincisal distance, Lateral excursion of mandible using digital caliper in millimeters and Visual Analogue Scale (VAS 0/10) for pain intensity score were used. All of these parameters were running through the intervals of two, four, and eight weeks till the end of the follow-up period at twenty-six weeks (six months). The participated patients showed the clinical improvement in the different clinical statuses such as interincisal distance; lateral excursion of mandible and Pain Score. Conclusion: the study reported early efficacy of PRGFs after the arthrocentesis of the joint in treatment of TMJ disc displacement, and according to our results, the injection of PRGFs could be a possible alternative treatment for patients who did not respond to standard treatment.